Is Abbott India (ABBOTINDIA) overvalued or fairly valued?

MarketChacha shows Abbott India's valuation in context — a forward P/E of about 31.3, a price-to-book of about 12.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Abbott India's revenue?

Abbott India reported revenue of ₹6,929 Cr for FY2026, with net profit of ₹1,552 Cr, per official filings.

What is the share price of Abbott India (ABBOTINDIA)?

Abbott India last traded at ₹28,455.00 (+1.4% on the day), as of 7/21/2026 — a delayed quote shown for education, not investment advice.

Abbott India

ABBOTINDIA · NSE · Pharma · India

₹28,455.00+1.4%

Delayed · as reported by Yahoo Finance · as of Jul 21, 2026, 5:36 AM

Snapshot

TickerABBOTINDIA

ExchangeNSE

SectorPharma

IndustryDrug Manufacturers - Specialty & Generic

CountryIndia

HeadquartersMumbai, India

Market cap₹60,082 Cr

P/B12.6

Volume5.9K

Websitewww.abbott.co.in

Filings tracked0

About Abbott India

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Profile as reported by Yahoo Finance.

Who owns it

Promoters75.5%
Institutions7.9%
Public & other16.5%

46 institutional holders

As reported by Yahoo Finance. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Net margin trend17.8% → 22.4%

Margin has expanded by about 4.6 points — the business is getting more profitable.

Growth qualityrev 9% · PAT 18%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next fiscal year

Rev ₹8,224 Cr · EPS 903.82

Est. earnings growth +12.4%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

₹25,150.0052-wk range₹35,310.00

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 4

Market cap

₹60,082 Cr

Day change

+1.4%

Fwd P/E

31.3

P/B

12.6

Div yield

1.87%

Beta

0.02

Revenue (FY2026)

₹6,929 Cr

Net margin

22.4%

Revenue CAGR (3y)

+9.0%

Profit CAGR (3y)

+17.8%

Net profit (FY2026)

₹1,552 Cr

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about ABBOTINDIA

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹6,929 Cr	₹1,552 Cr	22.4%
FY2025	₹6,409 Cr	₹1,414 Cr	22.1%
FY2024	₹5,849 Cr	₹1,201 Cr	20.5%
FY2023	₹5,349 Cr	₹949 Cr	17.8%

Quarterly

Period	Revenue	Net profit	Net margin
2026Q1	₹1,710 Cr	₹395 Cr	23.1%
2025Q4	₹1,724 Cr	₹376 Cr	21.8%
2025Q3	₹1,757 Cr	₹415 Cr	23.6%
2025Q2	₹1,738 Cr	₹366 Cr	21.0%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.